Home diagnostic tests are a Growth areas. Home Diagnosis allows hospitals and clinics to provide a complete telemedicine cycle, Reaching marginalized patients, and add more health codes to your insurance. Digital health companies can use home testing to pair and support products. As with any growing space, there is some confusion over the subtleties of home diagnosis. Is it FDA-cleared?Is it possible to collect blood samples on your own? phlebotomist? What is the difference between home testing and bedside testing? Whether you’re a doctor, member of a digital health organization, or a potential end user, here are five things you should know about home diagnostic tests.
Home diagnostic tests are CMS and CLIA certified, not just FDA
There are two organizations that play complementary roles in ensuring the compliance of laboratory diagnostics and the development of home diagnostics.The U.S. Food and Drug Administration (FDA) regulates manufacturers and devices Federal Food, Drug, and Cosmetic Act (FFDCA) ensures that devices, including those used to diagnose disease or other conditions, or to cure, alleviate, treat or prevent disease, are reasonably safe and effective.
This Centers for Medicare and Medicaid Services (CMS) and its Clinical Laboratory Improvement Amendments (CLIA) plans to regulate laboratories themselves to ensure accurate and reliable test results when testing patient samples. CLIA also demonstrated the validity of the analysis. Analytical validation under CLIA looks at the performance characteristics of the test used to describe the quality of patient test results, including analysis of accuracy, precision, analytical sensitivity, analytical specificity, reportable range, reference interval, and any other desired performance characteristics For test systems in laboratories that intend to use it.
Under CLIA regulations, when a laboratory uses a test system that is not FDA-approved or approved (such as an at-home developed laboratory), the laboratory must not publish any test results, such as CLIA’s accreditation, until certain performance characteristics have been determined. Analytical Validity Criteria.
Businesses can use modern systems to protect health data, not just HIPAA compliance
HIPAA is not the only tool for securing healthcare data. Health Insurance Portability and Accountability Act of 1996 (HIPAA) is a federal law that supports “national standards for protecting sensitive patient health information from disclosure without patient consent or knowledge.” HIPAA covers healthcare providers, health plans, healthcare clearinghouses and employees. However, businesses can use more modern technologies to protect health data, not just HIPAA. In fact, businesses are only required to comply with HIPAA when purchasing insurance. Some companies hire in-house engineers to build secure data transfer systems and portals. It is important to establish security protocols before asking customers to submit sensitive healthcare data.
Comprehensive home STI results require three site tests
Digital health companies, medical clinics, hospitals and public health programs have begun offering home health tests to combat Sexually transmitted infections are on the rise. HIV, hepatitis and syphilis blood test required, but chlamydia, gonorrhea, and trichomoniasis use swabs. While many businesses only offer single-site panels to test for STIs in the penis or vagina, these do not always reflect how individuals behave sexually, especially LGBTQ+ people. To accurately determine an individual’s true STI status, medical institutions and digital health companies must offer three-point testing and provide oral and anal swabs in addition to the penis or vagina. When working with providers or digital health companies, patients and clients should be aware of the limitations of single-point STI testing.
Reliable blood tests at home are possible
Home diagnostic providers can use a Dried Blood Spot (DBS) card to test a small amount of blood and ship it to a lab. The user pricks the blood from the fingertip and smears it on the card, where the filter paper absorbs the sample. The blood is dried in a fibrous matrix and then shipped in envelopes to a laboratory for testing.The DBS card test is slightly less sensitive for some markers due to the reduced sample size, but peer-reviewed studies have reported success in detecting diseases such as HIV, Hepatitis B and Cor Coronavirus disease Antibody. DBS cards can test for cancer, allergies, infectious diseases, fertility markers, comprehensive metabolic panels, sexually transmitted infections, and more. This type of home health test is especially useful for public health programs because street teams can transport sample blood without stabilizers.
Mail-in diagnosis is different from point-of-care testing
There is some confusion about the difference between home diagnostic tests and point-of-care tests. Users perform point-of-care tests outside the clinical setting, with results obtained in real time without the help of a doctor or laboratory technician.This Rapid Antigen Test for Covid-19 is an example of point-of-care testing. Home diagnostic tests performed at home are mailed to a lab where a technician processes the results. Home diagnostic tests are an extension of the health care system, whereas point-of-care tests do not require medical supervision. Both are alternatives to home phlebotomy, where a phlebotomist visits the user at the user’s home to draw blood for laboratory analysis.
Photo: Violeta Stomenova, Getty Images
